010203040Proportion of patients achieving goal at week 28 (%) HbA1c <7.0% HbA1c <7.0% with no body weight gain or major hypoglycaemia(B) Exenatide QW + IG (n = 231) Placebo + IG (n = 230) Exenatide QW + IG (n = 231)Placebo + IG (n = 230)-2.0-1.5-1.0-0.50.00.5 -35-30-25-20-15-10-505LSM (SE) change in 2-hour PPG (mmol/L)mg/dL(C) 67891011 110120130140150160170180190 Time (weeks)Mean (SE) FPG (mmol/L)mg/dL S- 8 - 4 0 8 4 1 21 62 02 42 8(D) n at week Exenatide QW 229   230     229        231       225       223       212       212       209       206        206 Placebo 229   227     229        230       227       226       216       215       211       208        2092* **** * â€  354045505560 Time (weeks)Mean (SE) insulin dose (units/day) S -8 -4 0 4 8 12 16 20 24 28(E) n at week Exenatide QW 230    230      230       231         229       226       221      217        215       212       210